Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biodesix, Inc. stock logo
BDSX
Biodesix
$16.32
+2.1%
$13.97
$5.00
$20.21
$169.01M0.4372,839 shs106,270 shs
Elevance Health, Inc. stock logo
ELV
Elevance Health
$394.40
+0.4%
$343.75
$273.71
$408.00
$85.29B0.661.47 million shs2.47 million shs
Globus Medical, Inc. stock logo
GMED
Globus Medical
$82.00
-0.5%
$87.01
$51.79
$101.40
$11.19B11.98 million shs1.97 million shs
Integer Holdings Corporation stock logo
ITGR
Integer
$89.55
-0.6%
$87.29
$62.00
$123.78
$3.06B0.67574,950 shs787,990 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biodesix, Inc. stock logo
BDSX
Biodesix
+2.06%+9.31%+65.85%+6.46%+137.76%
Elevance Health, Inc. stock logo
ELV
Elevance Health
+0.49%0.00%+4.81%+23.00%+4.38%
Globus Medical, Inc. stock logo
GMED
Globus Medical
-0.79%-3.35%-6.60%-14.04%+38.58%
Integer Holdings Corporation stock logo
ITGR
Integer
-0.52%+0.24%+7.14%+3.06%-25.06%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biodesix, Inc. stock logo
BDSX
Biodesix
$16.32
+2.1%
$13.97
$5.00
$20.21
$169.01M0.4372,839 shs106,270 shs
Elevance Health, Inc. stock logo
ELV
Elevance Health
$394.40
+0.4%
$343.75
$273.71
$408.00
$85.29B0.661.47 million shs2.47 million shs
Globus Medical, Inc. stock logo
GMED
Globus Medical
$82.00
-0.5%
$87.01
$51.79
$101.40
$11.19B11.98 million shs1.97 million shs
Integer Holdings Corporation stock logo
ITGR
Integer
$89.55
-0.6%
$87.29
$62.00
$123.78
$3.06B0.67574,950 shs787,990 shs
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biodesix, Inc. stock logo
BDSX
Biodesix
+2.06%+9.31%+65.85%+6.46%+137.76%
Elevance Health, Inc. stock logo
ELV
Elevance Health
+0.49%0.00%+4.81%+23.00%+4.38%
Globus Medical, Inc. stock logo
GMED
Globus Medical
-0.79%-3.35%-6.60%-14.04%+38.58%
Integer Holdings Corporation stock logo
ITGR
Integer
-0.52%+0.24%+7.14%+3.06%-25.06%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biodesix, Inc. stock logo
BDSX
Biodesix
2.33
Hold$22.0034.80% Upside
Elevance Health, Inc. stock logo
ELV
Elevance Health
2.61
Moderate Buy$403.112.21% Upside
Globus Medical, Inc. stock logo
GMED
Globus Medical
2.87
Moderate Buy$106.3629.72% Upside
Integer Holdings Corporation stock logo
ITGR
Integer
2.27
Hold$98.7110.23% Upside

Current Analyst Ratings Breakdown

Latest ITGR, BDSX, ELV, and GMED Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/28/2026
Integer Holdings Corporation stock logo
ITGR
Integer
Boost Price TargetNeutral$89.00 ➝ $92.00
5/26/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
Boost Price TargetOverweight$408.00 ➝ $480.00
5/22/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
Boost Price TargetBuy$400.00 ➝ $460.00
5/20/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
Boost Price TargetOutperform$385.00 ➝ $435.00
5/20/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
UpgradeHoldBuy$363.00 ➝ $498.00
5/19/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
Reiterated RatingHold
5/18/2026
Biodesix, Inc. stock logo
BDSX
Biodesix
DowngradeSell (D-)Sell (E+)
5/18/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
UpgradeHold (C-)Hold (C)
5/11/2026
Integer Holdings Corporation stock logo
ITGR
Integer
DowngradeHoldStrong Sell
5/8/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Lower Price TargetOverweight$104.00 ➝ $103.00
5/8/2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
Boost Price TargetOutperform$115.00 ➝ $120.00
(Data available from 5/30/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biodesix, Inc. stock logo
BDSX
Biodesix
$96.10M1.76N/AN/A$0.88 per share18.55
Elevance Health, Inc. stock logo
ELV
Elevance Health
$200.42B0.43$37.74 per share10.45$202.81 per share1.94
Globus Medical, Inc. stock logo
GMED
Globus Medical
$3.10B3.59$6.25 per share13.12$34.86 per share2.35
Integer Holdings Corporation stock logo
ITGR
Integer
$1.86B1.64$10.31 per share8.69$49.97 per share1.79
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biodesix, Inc. stock logo
BDSX
Biodesix
-$35.26M-$4.06N/AN/AN/A-33.26%-2,101.40%-35.65%8/6/2026 (Estimated)
Elevance Health, Inc. stock logo
ELV
Elevance Health
$5.66B$23.5116.7813.532.222.62%15.58%5.57%7/16/2026 (Estimated)
Globus Medical, Inc. stock logo
GMED
Globus Medical
$537.87M$4.3019.0716.201.7018.92%13.46%11.65%8/6/2026 (Estimated)
Integer Holdings Corporation stock logo
ITGR
Integer
$102.81M$4.0122.3313.252.157.64%12.83%6.51%7/23/2026 (Estimated)

Latest ITGR, BDSX, ELV, and GMED Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
Globus Medical, Inc. stock logo
GMED
Globus Medical
$0.92$1.12+$0.20$0.90$740.35 million$759.85 million
5/4/2026Q1 2026
Biodesix, Inc. stock logo
BDSX
Biodesix
-$1.1298-$0.81+$0.3198-$0.81$23.12 million$25.56 million
4/30/2026Q1 2026
Integer Holdings Corporation stock logo
ITGR
Integer
$1.21$1.20-$0.01$0.48$426.48 million$439.58 million
4/22/2026Q1 2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
$10.74$12.58+$1.84$8.00$48.21 billion$49.49 billion
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Biodesix, Inc. stock logo
BDSX
Biodesix
N/AN/AN/AN/AN/A
Elevance Health, Inc. stock logo
ELV
Elevance Health
$6.881.74%+12.47%29.26%14 Years
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/AN/AN/AN/AN/A
Integer Holdings Corporation stock logo
ITGR
Integer
N/AN/AN/AN/AN/A

Latest ITGR, BDSX, ELV, and GMED Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
4/21/2026
Elevance Health, Inc. stock logo
ELV
Elevance Health
quarterly$1.722.11%6/10/20266/10/20266/25/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biodesix, Inc. stock logo
BDSX
Biodesix
5.09
2.82
2.82
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.70
1.48
1.48
Globus Medical, Inc. stock logo
GMED
Globus Medical
N/A
4.56
2.95
Integer Holdings Corporation stock logo
ITGR
Integer
0.77
3.75
2.38

Institutional Ownership

CompanyInstitutional Ownership
Biodesix, Inc. stock logo
BDSX
Biodesix
20.96%
Elevance Health, Inc. stock logo
ELV
Elevance Health
89.24%
Globus Medical, Inc. stock logo
GMED
Globus Medical
95.16%
Integer Holdings Corporation stock logo
ITGR
Integer
99.29%

Insider Ownership

CompanyInsider Ownership
Biodesix, Inc. stock logo
BDSX
Biodesix
23.20%
Elevance Health, Inc. stock logo
ELV
Elevance Health
0.34%
Globus Medical, Inc. stock logo
GMED
Globus Medical
18.38%
Integer Holdings Corporation stock logo
ITGR
Integer
1.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Biodesix, Inc. stock logo
BDSX
Biodesix
22010.36 million7.95 millionNo Data
Elevance Health, Inc. stock logo
ELV
Elevance Health
97,100217.16 million216.42 millionOptionable
Globus Medical, Inc. stock logo
GMED
Globus Medical
6,000135.75 million110.80 millionOptionable
Integer Holdings Corporation stock logo
ITGR
Integer
11,00033.96 million33.58 millionOptionable

Recent News About These Companies

Integer Holdings Corp
Integer Holdings Earnings Call Flags Tough 2026
Integer Holdings: Rare Public Asset Soon To Be Sold
Integer Holdings Maps Through 2026 Earnings Speed Bump

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Biodesix stock logo

Biodesix NASDAQ:BDSX

$16.32 +0.33 (+2.06%)
Closing price 05/29/2026 04:00 PM Eastern
Extended Trading
$16.23 -0.09 (-0.58%)
As of 05/29/2026 05:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Elevance Health stock logo

Elevance Health NYSE:ELV

$394.40 +1.65 (+0.42%)
Closing price 05/29/2026 03:59 PM Eastern
Extended Trading
$393.62 -0.78 (-0.20%)
As of 05/29/2026 07:12 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Elevance Health, Inc., together with its subsidiaries, operates as a health benefits company in the United States. The company operates through four segments: Health Benefits, CarelonRx, Carelon Services, and Corporate & Other. It offers a variety of health plans and services to program members; health products; an array of fee-based administrative managed care services; and specialty and other insurance products and services, such as stop loss, dental, vision, life, disability, and supplemental health insurance benefits. The company operates in the pharmacy services business; and markets and offers pharmacy services, including pharmacy benefit management, as well as home delivery and specialty pharmacies, claims adjudication, formulary management, pharmacy networks, rebate administration, a prescription drug database, and member services. In addition, it provides healthcare-related services and capabilities, including utilization management, behavioral health, integrated care delivery, palliative care, payment integrity services, subrogation services, and health and wellness programs, as well as services related to data management, information technology, and business operations. Further, the company is involved in the National Government Services business. The company provides its services under the Anthem Blue Cross and Blue Shield, Wellpoint, and Carelon brand names. The company was formerly known as Anthem, Inc. and changed its name to Elevance Health, Inc. in June 2022. Elevance Health, Inc. was incorporated in 2001 and is headquartered in Indianapolis, Indiana.

Globus Medical stock logo

Globus Medical NYSE:GMED

$82.00 -0.45 (-0.55%)
Closing price 05/29/2026 03:59 PM Eastern
Extended Trading
$81.91 -0.09 (-0.11%)
As of 05/29/2026 07:59 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Globus Medical, Inc., a medical device company, develops and commercializes healthcare solutions for patients with musculoskeletal disorders in the United States and internationally. The company offers spine products, such as traditional fusion implants comprising pedicle screw and rod systems, plating systems, intervertebral spacers, and corpectomy devices for treating degenerative and congenital conditions, deformity, tumors, and trauma injuries; treatment options for motion preservation technologies that consist of dynamic stabilization, total disc replacement, and interspinous distraction devices; interventional solutions to treat vertebral compression fractures; and regenerative biologic products comprising of allografts and synthetic alternatives. It also offers products for the treatment of orthopedic trauma, including fracture plates, compression screws, intramedullary nails, and external fixation systems; and hip and knee joint solutions, including modular hip stems and acetabular cups, as well as posterior stabilizing and cruciate retaining knee arthroplasty implants. In addition, the company distributes human cell, tissue, and cellular and tissue-based products. It sells its products through direct or distributor sales representatives, as well as hip and knee products through independent sales agents. Globus Medical, Inc. was incorporated in 2003 and is headquartered in Audubon, Pennsylvania.

Integer stock logo

Integer NYSE:ITGR

$89.55 -0.50 (-0.55%)
Closing price 05/29/2026 03:59 PM Eastern
Extended Trading
$90.00 +0.45 (+0.50%)
As of 05/29/2026 05:40 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures. It also provides cardiac rhythm management products, including implantable pacemakers, implantable cardioverter defibrillators, insertable cardiac monitors, implantable cardiac pacing and defibrillation leads, and heart failure therapies; neuromodulation products, such as implantable spinal cord stimulators; and non-rechargeable batteries, feedthroughs, device enclosures, machined components, and lead components and sub-assemblies. In addition, the company offers rechargeable batteries and chargers; and arthroscopic, laparoscopic, and general surgery devices and components, such as harmonic scalpels, shaver blades, burr shavers, radio frequency probes, biopsy probes, trocars, electrocautery components, wound dressings, GERD treatment components, and phacoemulsification needles. Further, it provides orthopedic products that include instruments used in hip, knee, and spine surgeries, as well as reamers and chisels. Additionally, the company offers customized battery power and power management systems, and battery solutions for the energy, military, and environmental markets. Furthermore, the company provides medical technologies. It serves multi-national original equipment manufacturers and their affiliated subsidiaries in the cardiac rhythm management, neuromodulation, orthopedics, vascular, and advanced surgical and portable medical markets. Integer Holdings Corporation was founded in 1970 and is headquartered in Plano, Texas.